This site is intended for healthcare professionals

Genentech/Roche announced a higher-dose phase III clinical trial program for Ocrevus and a distinct Ocrevus trial specifically to support African-American and Hispanic- and Latin-American patients with Multiple Sclerosis.

Read time: 1 mins
Last updated:16th Mar 2021
Published:10th Sep 2020
Condition: Multiple Sclerosis
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest